Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

NCT01140607 ·Status: COMPLETED ·Phase: PHASE1

BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

NCT00004927 ·Status: COMPLETED ·Phase: PHASE1

A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors

NCT01004822 ·Status: TERMINATED ·Phase: PHASE1

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN

NCT04317105 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

BMS-247550 in Treating Patients With Advanced Cancers

NCT00006221 ·Status: COMPLETED ·Phase: PHASE1

A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06630247 ·Status: TERMINATED ·Phase: PHASE1

A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors

NCT00999401 ·Status: COMPLETED ·Phase: PHASE1

A Study of BI 3810944 in Patients With Advanced Cancer

NCT07224425 ·Status: RECRUITING ·Phase: PHASE1

A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours

NCT02952248 ·Status: COMPLETED ·Phase: PHASE1

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors

NCT00796484 ·Status: TERMINATED ·Phase: PHASE1

Study of XL999 in Adults With Solid Tumors

NCT00104117 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer

NCT00422097 ·Status: COMPLETED ·Phase: PHASE1

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

NCT04250155 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

NCT01755390 ·Status: COMPLETED ·Phase: PHASE1

Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.

NCT00849550 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors

NCT06873789 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma

NCT00947739 ·Status: COMPLETED ·Phase: PHASE1

Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies

NCT00207129 ·Status: COMPLETED ·Phase: PHASE1

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

NCT01421524 ·Status: COMPLETED ·Phase: PHASE1

Solid Tumors Using Ixabepilone and Dasatinib

NCT00717704 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies

NCT03447470 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors

NCT00395434 ·Status: COMPLETED ·Phase: PHASE1

XTX202 in Patients With Advanced Solid Tumors

NCT05052268 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of ABT-414 in Subjects With Solid Tumors

NCT01741727 ·Status: COMPLETED ·Phase: PHASE1